Clinical Trial Update: A Study Comparing the Blood Levels of Both Pegaspargase (S95014) Formulations (Liquid vs Lyophilized) in the Treatment of Paediatric Patients With Acute Lymphoblastic Leukemia (ALL) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing liquid vs. lyophilized pegylated asparaginase (S95014) formulations in pediatric acute lymphoblastic leukemia; study completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Pegaspargase (S95014) (pegaspargase)

Snippet

Sponsor: Institut de Recherches Internationales Servier | Conditions: Acute Lymphoblastic Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2023-07-05